Dawson James Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.CompanyDateActionBrokerageRatingPrice TargetImpact on PriceActionsCHEKCheck Cap12/5/2019Initiated byDawson JamesBuy $4.00Low DYAIDyadic International10/16/2019Initiated byDawson JamesBuy $14.00Low EMMAEmmaus Life Sciences9/24/2019Downgraded byDawson JamesBuy -> NeutralHigh BCDABioCardia9/17/2019Initiated byDawson JamesBuy $24.00Low BCDABiocardia9/17/2019Reiterated byDawson JamesBuyMedium CTXRCitius Pharmaceuticals9/6/2019Initiated byDawson JamesBuy $7.00N/A FBIOFortress Biotech8/26/2019Initiated byDawson JamesBuy $19.00High ATHXAthersys8/26/2019Initiated byDawson JamesBuy $11.00High ADMAADMA Biologics8/12/2019Downgraded byDawson JamesBuy -> Neutral $4.00High AVXLAnavex Life Sciences7/24/2019Initiated byDawson JamesBuy $16.00Low DMPIDelMar Pharmaceuticals7/11/2019Reiterated byDawson JamesBuyHigh ISRIsoRay7/1/2019Initiated byDawson JamesBuyN/A ADMPAdamis Pharmaceuticals7/2/2019Initiated byDawson JamesBuyMedium SBPHSpring Bank Pharmaceuticals5/13/2019Reiterated byDawson JamesBuyLow ADILAdial Pharmaceuticals4/12/2019Reiterated byDawson JamesBuyMedium FNJNFinjan3/29/2019Reiterated byDawson JamesBuyHigh CLBSCaladrius Biosciences2/27/2019Reiterated byDawson JamesBuyMedium BTXBioTime2/7/2019Initiated byDawson JamesBuyN/A NAOVNanoVibronix1/9/2019Initiated byDawson JamesBuyLow INTTinTest12/28/2018Reiterated byDawson JamesBuyHigh INTTinTEST12/28/2018Reiterated byDawson JamesBuyN/A SITOSito Mobile12/21/2018Reiterated byDawson JamesBuyLow ORGSOrgenesis12/20/2018Reiterated byDawson JamesBuyHigh SSNTSilverSun Technologies12/19/2018Reiterated byDawson JamesBuyHigh BCLIBrainstorm Cell Therapeutics12/18/2018Reiterated byDawson JamesBuyHigh ORGSOrgenesis12/20/2018Initiated byDawson JamesBuy -> BuyMedium GVPGSE Systems, Inc. (NASDAQ)12/18/2018Reiterated byDawson JamesBuyHigh FTNWFTE Networks12/11/2018Reiterated byDawson JamesBuyN/A FTNWFTE Networks12/11/2018Reiterated byDawson JamesBuyHigh WYYWidePoint12/3/2018Reiterated byDawson JamesBuyHigh WTTWireless Telecom Group12/3/2018Reiterated byDawson JamesBuyLow WYYWidePoint12/3/2018Reiterated byDawson JamesBuyN/A ONCSOncoSec Medical11/7/2018Downgraded byDawson JamesBuy -> NeutralLow ALSKAlaska Communications Systems Group10/29/2018Initiated byDawson JamesBuyMedium TEUMPareteum10/25/2018Reiterated byDawson JamesBuyLow CIDMCinedigm10/22/2018Initiated byDawson JamesBuyLow IDXGInterpace Diagnostics Group10/17/2018Initiated byDawson JamesBuy $4.00High ADILAdial Pharmaceuticals10/11/2018Initiated byDawson JamesBuyHigh FENCFennec Pharmaceuticals10/11/2018Initiated byDawson JamesBuyHigh BIOCBiocept10/3/2018Reiterated byDawson JamesBuyHigh ADILAdial Pharmaceuticals10/1/2018Reiterated byDawson JamesBuyLow LUNALuna Innovations10/2/2018Initiated byDawson JamesBuyLow SGLBSigma Labs9/27/2018Reiterated byDawson JamesBuyHigh SSKNSTRATA Skin Sciences9/4/2018Initiated byDawson JamesBuyHigh CHFSCHF Solutions8/28/2018Initiated byDawson JamesBuy $3.30High ONCSOncoSec Medical7/16/2018Reiterated byDawson JamesBuyLow VERUVeru6/25/2018Reiterated byDawson JamesBuyMedium IMVIMV6/19/2018Reiterated byDawson JamesBuyN/A IMVIMV6/19/2018Reiterated byDawson JamesBuyMedium LIVXLivexlive Media6/4/2018Reiterated byDawson JamesBuyMedium ALTAltimmune5/29/2018Reiterated byDawson JamesBuyHigh FNJNFinjan5/22/2018Reiterated byDawson JamesBuyLow CSBRChampions Oncology5/15/2018Initiated byDawson JamesBuy $10.00Low CGIXCancer Genetics4/6/2018Downgraded byDawson JamesBuy -> NeutralHigh ACSTAcasti Pharma1/29/2018Reiterated byDawson JamesBuyLow CVMCEL-SCI10/16/2017Reiterated byDawson JamesNeutralN/A PULMPulmatrix9/27/2017Reiterated byDawson JamesBuyMedium TEUMPareteum9/22/2017Reiterated byDawson JamesBuyN/A PAVMPAVmed9/5/2017Reiterated byDawson JamesBuy $10.10High TNXPTonix Pharmaceuticals8/23/2017Reiterated byDawson JamesBuy $90.00Medium DMPIDelMar Pharmaceuticals8/8/2017Reiterated byDawson JamesBuyHigh SBPHSpring Bank Pharmaceuticals8/7/2017Reiterated byDawson JamesBuyLow EPIXESSA Pharma8/3/2017Reiterated byDawson JamesBuyHigh ONTXOnconova Therapeutics7/25/2017Reiterated byDawson JamesBuyHigh ONCSOncoSec Medical7/6/2017Reiterated byDawson JamesBuy $50.00High CGIXCancer Genetics6/27/2017Initiated byDawson JamesBuyHigh OPGNOpGen6/19/2017Reiterated byDawson JamesBuyLow SBPHSpring Bank Pharmaceuticals11/6/2016Reiterated byDawson JamesBuyN/A PARNFParnell Pharmaceuticals5/24/2016Reiterated byDawson JamesBuyN/A CVMCEL-SCI3/11/2016Reiterated byDawson JamesBuyN/A NURONeurometrix2/29/2016Reiterated byDawson JamesBuyN/A ENZEnzo Biochem2/9/2016Reiterated byDawson JamesBuyN/A SLNOSoleno Therapeutics5/6/2015Initiated byDawson JamesBuy $63.50N/A CVMCEL-SCI3/2/2015Initiated byDawson JamesBuy $3.00N/A PULMPulmatrix6/25/2014Initiated byDawson JamesBuy $120.00N/A AXGNAxoGen5/14/2014Initiated byDawson JamesBuy $5.00N/A NEONeoGenomics5/14/2014Initiated byDawson JamesBuy $6.00N/A ABIOArca Biopharma10/9/2013Initiated byDawson JamesBuy $3.75N/A AGENAgenus3/12/2013Reiterated byDawson JamesBuyN/A MDMEDNAX3/12/2013Downgraded byDawson JamesBuy -> Neutral $80.00N/A ARWRArrowhead Pharmaceuticals2/26/2013Initiated byDawson JamesBuy $4.00N/A ATOSAtossa Genetics12/20/2012Initiated byDawson JamesOutperform $120.00N/A CELGCelgene12/12/2012Reiterated byDawson JamesMarket Outperform $51.00N/A GEOThe GEO Group12/4/2012Downgraded byDawson JamesMarket PerformN/A NAVBNavidea Biopharmaceuticals11/27/2012Initiated byDawson JamesOutperformN/A CLSNCelsion11/27/2012Initiated byDawson JamesOutperform $126.00N/A SPPISpectrum Pharmaceuticals11/27/2012Initiated byDawson JamesOutperform $15.00N/A SRPTSarepta Therapeutics11/27/2012Initiated byDawson JamesOutperformN/A RMTIRockwell Medical11/27/2012Initiated byDawson JamesOutperform $12.00N/A AGENAgenus11/27/2012Initiated byDawson JamesOutperformN/A AFFYAffymax11/27/2012Initiated byDawson JamesOutperform $32.00N/A CYTKCytokinetics11/27/2012Downgraded byDawson JamesOutperformN/A GALTGalectin Therapeutics7/6/2012Target Lowered byDawson JamesBuy $3.00N/A TNXPTonix Pharmaceuticals4/26/2012Initiated byDawson JamesBuy $40.00N/A NFLXNetflix10/28/2011Target Lowered byDawson JamesSell$16.50 -> $7.14N/A IMUCImmunoCellular Therapeutics3/22/2011Initiated byDawson JamesBuy $5.00N/A This page was last refreshed on Sunday at 10:36 AM ET.MarketBeat Community Rating for Dawson JamesCommunity Ranking: 1.9 out of 5 ( )Outperform Votes: 17,642 (Vote Outperform)Underperform Votes: 28,118 (Vote Underperform)Total Votes: 45,760MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days. See Also: U.S. Analyst Ratings U.K. Analyst Ratings Canadian Analyst Ratings European Analyst Ratings Analyst Ratings by Company Analyst Ratings by Issuer